Cencora, Inc.

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cencora, Inc. and other ETFs, options, and stocks.

About COR

Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. 

CEO
Robert P. Mauch
CEORobert P. Mauch
Employees
51,000
Employees51,000
Headquarters
Conshohocken, Pennsylvania
HeadquartersConshohocken, Pennsylvania
Founded
1947
Founded1947
Employees
51,000
Employees51,000

COR Key Statistics

Market cap
52.41B
Market cap52.41B
Price-Earnings ratio
20.66
Price-Earnings ratio20.66
Dividend yield
0.85%
Dividend yield0.85%
Average volume
1.93M
Average volume1.93M
High today
$272.27
High today$272.27
Low today
$266.26
Low today$266.26
Open price
$270.51
Open price$270.51
Volume
3.07M
Volume3.07M
52 Week high
$377.54
52 Week high$377.54
52 Week low
$244.82
52 Week low$244.82

Stock Snapshot

As of today, Cencora, Inc.(COR) shares are valued at $269.36. The company's market cap stands at 52.41B, with a P/E ratio of 20.66 and a dividend yield of 85.4%.

As of 2026-05-30, Cencora, Inc.(COR) stock has fluctuated between $266.26 and $272.27. The current price stands at $269.36, placing the stock +1.2% above today's low and -1.1% off the high.

Cencora, Inc.(COR) shares are trading with a volume of 3.07M, against a daily average of 1.93M.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $244.82.

In the last year, Cencora, Inc.(COR) shares hit a 52-week high of $377.54 and a 52-week low of $244.82.

COR News

Simply Wall St 12h
Assessing Cencora Valuation After Recent Share Price Weakness And Long Term Gains

Advertisement Recent share performance snapshot Cencora (COR) has seen its stock decline about 13% over the past month and roughly 28% over the past 3 months,...

Assessing Cencora Valuation After Recent Share Price Weakness And Long Term Gains
TipRanks 22h
Cencora Names New CFO and Reaffirms 2026 Outlook

Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-co...

TipRanks 2d
Cencora Insider Makes Bold Multi-Million-Dollar Move in Fresh Stock Buy

New insider activity at Cencora ( (COR) ) has taken place on May 28, 2026. Unlock trusted, data-backed investing tools with TipRanks Premium, from analyst rati...

Analyst ratings

83%

of 18 ratings
Buy
83.3%
Hold
16.7%
Sell
0%

More COR News

Simply Wall St 3d
Is Cencora Starting To Look Attractive After Recent Healthcare Distribution Headlines?

If you are wondering whether Cencora at about US$270.78 is starting to look attractive or stretched, the key question is what you are really paying for its futu...

Is Cencora Starting To Look Attractive After Recent Healthcare Distribution Headlines?
TipRanks 3d
Cencora appoints Eva Boratto as CFO

Cencora (COR) appointed Eva Boratto EVP and CFO, effective June 29. Boratto succeeds James Cleary, who will be retiring from his role as EVP and CFO as previous...

People also own

Based on the portfolios of people who own COR. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.